 |
|
Assessing Cancer Prevention Studies—A Matter of Time
Bettina F. Drake, PhD, MPH;
Graham A. Colditz, MD, DrPH
JAMA. 2009;302(19):2152-2153.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To reduce the incidence of neural tube defects, the US Food and Drug Administration (FDA) mandated folic acid fortification of flour and other grains beginning in 1998.1 Subsequent studies showed an overall increase in mean folic acid levels among US residents.2-3 Within a few years of this mandate, a decrease in the incidence of neural tube defects was noted in newborns.4 However, longer-term benefits of folic acid fortification for disease prevention,5 including multiple cancers,6-8 remain to be documented. Animal studies suggest that modest supplementation can reduce carcinogenesis. On the other hand, high doses of folic acid may speed cell division and increase tumor progression in preneoplastic lesions.9-10 Better understanding of time frame and dosage is key to balancing risk and benefits.
In this issue of JAMA, Ebbing et al11 present evidence of the association between folic acid treatment and . . . [Full Text of this Article]
Author Affiliations: Alvin J. Siteman Cancer Center and Washington University in St Louis School of Medicine, Department of Surgery, St Louis, Missouri.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12
Marta Ebbing, Kaare Harald Bønaa, Ottar Nygård, Egil Arnesen, Per Magne Ueland, Jan Erik Nordrehaug, Knut Rasmussen, Inger Njølstad, Helga Refsum, Dennis W. Nilsen, Aage Tverdal, Klaus Meyer, and Stein Emil Vollset
JAMA. 2009;302(19):2119-2126.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Folic Acid and Cancer
JWatch General 2009;2009:1-1.
FULL TEXT
|
